Treatment of pancreatic cancer cells with IL-9 decreased miR-200a expression and increased β-catenin expression; the effect of miR-200a on pancreatic cancer cells was reduced by IL-9 treatment. The gene discussed is IL9; the disease is familial pancreatic carcinoma.